September 4, 2019, Nashville, TN - Dr. Josh Frenkel (MD, MPH) of Wang Vision Institute has performed Tennessee's first laser trifocal intraocular lens implant.
Approved by the United States Food and Drug Administration in September of 2019, trifocal intraocular lens (Panoptix) represents a revolution in lens technology after cataract surgery in the last 10 years. “At Wang Vision, we are proud to be able to introduce this new vision technology to the state again, and enable the patients in our state to enjoy the excitingly new and wider range of vision,'' Dr. Wang said.
Just like trifocal glasses, the trifocal intraocular lenses offer patients excellent vision in all three ranges, distance, intermediate and near. Dr. Wang explains that up until now, the technology has been limited to bifocal lenses, and some of the patients have somewhat diminished vision in the mid range when the lens is targeted for distance and near. “Our current technology can satisfy 2 out of 3 ranges of human vision needs, and often, our patients are put into position of having to choose which 2 out of 3 ranges that they want, sacrificing the remaining one. The new trifocal lens will enable the appropriate patients to be able to improve vision in all three ranges. This is an exciting, unprecedented and breakthrough eye technology,” Dr. Wang said.
Not everyone is a candidate for the new trifocal lens technology. Dr. Wang emphasized the safety and vision performance can only be obtained if the patient is a right candidate and the surgery is performed with the best technology available such as laser-assisted cataract surgery which was introduced to Tennessee also by the doctors at Wang Vision.